10208T

5/13

第1章腫瘍免疫学の基礎知識8免疫抑制細胞（総論）8．免疫抑制細胞（総論）51　は，本章「9. 制御性T細胞」（p.52参照）を参照されたい13）。■文献 1） Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013；39（4）：782-95. 2） Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer sup-pression and promotion. Science. 2011；331（6024）：1565-70. 3） Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017；541（7637）：321-30. 4） Sharma P, Hu-Lieskovan S, Wargo JA, et al. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017；168（4）：707-23. 5） Sugiyama E, Togashi Y, Takeuchi Y, et al. Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non‒small cell lung cancer. Sci Immunol. 2020；5（43）：eaav3937. 6） Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006；8（4）：315‒7. 7） Desbois M, Wang Y. Cancer-associated fibroblasts: Key players in shaping the tumor immune mi-croenvironment. Immunol Rev. 2021；302（1）：241-58. 8） Payne LB, Zhao H, James CC, et al. The pericyte microenvironment during vascular development. Microcirculation. 2019；26（8）：e12554. 9） Wu K, Lin K, Li X, et al. Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment. Front Immunol. 2020；11：1731.10） Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002；23（11）：549-55.11） Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021；21（8）：485-98.12） Sarvaria A, Madrigal JA, Saudemont A. B cell regulation in cancer and anti-tumor immunity. Cell Mol Immunol. 2017；14（8）：662-74.13） Wing JB, Tanaka A, Sakaguchi S. Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer. Immunity. 2019；50（2）：302-16.（赤塚美樹・西川博嘉）